首页> 美国卫生研究院文献>Diagnostic and Therapeutic Endoscopy >The Use of Endobronchial Ultrasound in the Diagnosis of Subacute Pulmonary Histoplasmosis
【2h】

The Use of Endobronchial Ultrasound in the Diagnosis of Subacute Pulmonary Histoplasmosis

机译:支气管内超声在亚急性肺组织胞浆菌病诊断中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective. Endobronchial ultrasound (EBUS) utility in diagnosis in malignant and granulomatous mediastinal disease has been well demonstrated. We propose to examine the role of EBUS transbronchial needle aspiration (EBUS-TBNA) in the diagnosis of subacute pulmonary histoplasmosis (SPH) with mediastinal lymphadenopathy in an area where histoplasmosis is endemic. Methods. A retrospective review was performed in a single academic institution between 2009 and 2012 of patients referred for EBUS-TBNA who had radiographic imaging and clinical symptomatology suspicious for SPH. Seven patients were reviewed. TBNA results showing granulomatous disease with areas of necrosis in the appropriate clinical setting were considered to be adequate for the diagnosis of SPH when alternative diagnosis was excluded. Patients underwent further clinical follow-up of 12 months to determine the final diagnosis. Results. All seven patients were felt to have SPH diagnosis reached by a combination of clinical presentation, EBUS-TBNA results, fungal serologies, and antigen testing. None of the patients needed further invasive procedures. Conclusions. EBUS-TBNA is a minimally invasive tool that can be used to support a diagnosis of SPH in patients with a high degree of clinical suspicion. EBUS-TBNA should be considered as an adjunctive diagnostic procedure for patients with SPH in an appropriate clinical setting.
机译:目的。支气管内超声(EBUS)在恶性和肉芽肿性纵隔疾病诊断中的效用已得到充分证明。我们建议检查在组织胞浆菌病流行的地区,EBUS经支气管针抽吸术(EBUS-TBNA)在诊断为纵隔淋巴结病的亚急性肺组织胞浆菌病(SPH)中的作用。方法。在2009年至2012年间,对一所转诊为EBUS-TBNA且影像学检查和临床症状学可疑为SPH的EBUS-TBNA患者进行了回顾性审查。七名患者进行了审查。 TBNA结果显示,在适当的临床环境中,肉芽肿性疾病伴有坏死区域,在排除其他诊断后,被认为足以诊断SPH。患者接受了12个月的进一步临床随访以确定最终诊断。结果。通过临床表现,EBUS-TBNA结果,真菌血清学和抗原检测相结合,认为所有7例患者均已达到SPH诊断。没有患者需要进一步的侵入性手术。结论。 EBUS-TBNA是一种微创工具,可用于支持高度怀疑临床的SPH诊断。对于在适当临床条件下患有SPH的患者,应考虑将EBUS-TBNA作为辅助诊断程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号